Literature DB >> 12130479

Do B-cell chronic lymphocytic leukemia patients with Ig VH3-21 genes constitute a new subset of chronic lymphocytic leukemia?

Friedel Nollet, Barbara Cauwelier, Johan Billiet, Dominik Selleslag, Achiel Van Hoof, Andries Louwagie, Arnold Criel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12130479     DOI： 10.1182/blood-2002-03-0867

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  CD5+ diffuse large B-cell lymphoma consists of germline cases and hypermutated cases in the immunoglobulin heavy chain gene variable region.

Authors:  Naoya Nakamura; Shigeo Nakamura; Motoko Yamaguchi; Ryo Ichinohasama; Tadashi Yoshino; Tetsuo Kuze; Yoshikazu Sasaki; Sachiko Yoshida; Masafumi Abe
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

2.  Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.

Authors:  Emanuela M Ghia; Sonia Jain; George F Widhopf; Laura Z Rassenti; Michael J Keating; William G Wierda; John G Gribben; Jennifer R Brown; Kanti R Rai; John C Byrd; Neil E Kay; Andrew W Greaves; Thomas J Kipps
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

3.  Comprehensive characterization of immunoglobulin gene rearrangements in patients with chronic lymphocytic leukaemia.

Authors:  Céline René; Nathalie Prat; Audrey Thuizat; Mélanie Broctawik; Odile Avinens; Jean-François Eliaou
Journal:  J Cell Mol Med       Date:  2014-04-11       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.